Siyuan Chen
About Siyuan Chen
Siyuan Chen is the General Manager and President of China and Hong Kong at 百时美施贵宝, with extensive experience in the pharmaceutical industry and a strong background in infectious and rare diseases.
Company
Siyuan Chen is currently the General Manager and President of China and Hong Kong operations at 百时美施贵宝, based in Shanghai. Since December 2019, Chen has been at the helm of operations, working towards enhancing the company's footprint in the region.
Title
As the General Manager and President of China and Hong Kong at 百时美施贵宝, Siyuan Chen leads the strategic and operational functions within these territories. Chen's role entails overseeing commercial operations, optimizing business strategies, and driving growth in these key regions.
Education and Expertise
Siyuan Chen holds an MBA in Finance and General Management from Columbia Business School, completed between 2005 and 2007. Chen also has a Bachelor of Science in Biochemistry from Fudan University. With this solid educational background, Chen showcases extensive expertise in managing commercial operations in the pharmaceutical industry, especially in specialty care and vaccines.
Professional Background
Siyuan Chen has a diverse international professional background, having held notable positions in various locations. Before joining 百时美施贵宝, Chen was the VP, Head of Respiratory and HIV at 葛兰素史克公司 in Shanghai from 2017 to 2019. Prior to 2017, Chen served as VP, Commercial Head, Asia Pacific at ViiV Healthcare in Hong Kong. Between 2009 and 2015, Chen worked at Novartis in Basel Area, Switzerland, as Strategic Assistant to the Division Head, Vaccines. Additionally, Chen's career includes a tenure at Boston Consulting Group as a Consultant from 2007 to 2009 in Shanghai.
Leadership and Achievements
Siyuan Chen has a proven track record of leadership within multinational corporations and consulting firms, demonstrating a history of strategic and business development initiatives. With extensive experience in managing commercial operations and a solid background in infectious and rare diseases, Chen has contributed to significant projects in the pharmaceutical sector across regions like Shanghai, Hong Kong, and Basel.